20:47 , Nov 6, 2018 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Influenza virus Cell culture and mouse studies suggest a quadspecific antibody against influenza A and influenza B HA epitopes could help prevent infection by multiple strains of influenza A and influenza B viruses. The...
22:37 , Nov 1, 2018 |  BC Extra  |  Preclinical News

Llama antibodies could provide universal flu protection

Researchers at Janssen Pharmaceuticals Inc. and the Scripps Research Institute have created a prophylactic universal flu therapy by combining four llama antibodies into a single protein. Most flu vaccines stimulate the generation of antibodies against...
01:12 , Dec 13, 2017 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Influenza virus In vitro and mouse studies suggest a chimeric mAb against influenza B HA epitope could help treat influenza B. The mAb was generated by immunizing mice with two influenza B viruses, isolating...
07:00 , Aug 30, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Influenza virus Influenza A virus hemagglutinin (HA); influenza B HA In vitro and mouse studies suggest human mAbs could be used to treat or...
07:00 , Aug 23, 2012 |  BC Innovations  |  Targets & Mechanisms

Broader is better

A team from the Crucell Vaccine Institute and The Scripps Research Institute has identified a trio of neutralizing human mAbs that protect mice from challenge with influenza viruses, including one mAb that protects against both...